We are live on ! Find out more
CLSD

Clearside Biomedical
CLSD

Delisted

CLSD was delisted on the 28th of November, 2025.

Back to rankings

1 hedge funds and large institutions have $19.1K invested in Clearside Biomedical in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.19% less ownership

Funds ownership: 0.7% → 0.52% (-0.19%)

96% less funds holding

Funds holding: 26 → 1 (-25)

96% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 26

99% less capital invested

Capital invested by funds: $2.18M → $19.1K (-$2.17M)

Holders
1
Holders Change
-25
Holders Change %
-96.15%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
26
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DS
DRW Securities
Illinois
+$95.6K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$881K
2
CG
Carmignac Gestion
France
-$399K
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$209K
4
BlackRock
BlackRock
New York
-$165K
5
Renaissance Technologies
Renaissance Technologies
New York
-$100K
Name Holding Trade Value Shares
Change 		Change in
Stake
DS
1
DRW Securities
Illinois
$19.1K +$95.6K +27,136 New
Vanguard Group
2
Vanguard Group
Pennsylvania
– -$881K -221,968 Closed
CG
3
Carmignac Gestion
France
– -$399K -100,556 Closed
Geode Capital Management
4
Geode Capital Management
Massachusetts
– -$209K -52,741 Closed
BlackRock
5
BlackRock
New York
– -$165K -41,677 Closed
Renaissance Technologies
6
Renaissance Technologies
New York
– -$100K -25,247 Closed
AWM
7
Apollon Wealth Management
South Carolina
– -$93.6K -23,586 Closed
First Manhattan
8
First Manhattan
New York
– -$90.7K -22,846 Closed
State Street
9
State Street
Massachusetts
– -$65.1K -16,387 Closed
GCP
10
GSA Capital Partners
United Kingdom
– -$51K -12,885 Closed
Northern Trust
11
Northern Trust
Illinois
– -$43.8K -11,032 Closed
UBS Group
12
UBS Group
Switzerland
– -$36.9K -9,303 Closed
PNC Financial Services Group
13
PNC Financial Services Group
Pennsylvania
– -$28.6K -7,194 Closed
NMG
14
New Millennium Group
Utah
– -$11.7K -2,952 Closed
Osaic Holdings
15
Osaic Holdings
Arizona
– -$900 -2,500 Closed
Morgan Stanley
16
Morgan Stanley
New York
– -$2.98K -750 Closed
Wells Fargo
17
Wells Fargo
California
– -$1.59K -400 Closed
Bank of America
18
Bank of America
North Carolina
– -$469 -118 Closed
Fidelity Investments
19
Fidelity Investments
Massachusetts
– -$330 -83 Closed
CIBC Private Wealth Group
20
CIBC Private Wealth Group
Georgia
– -$290 -73 Closed
FC
21
Financial Consulate
Maryland
– -$263 -66 Closed
SS
22
SBI Securities
Japan
– -$202 -51 Closed
JP Morgan Chase
23
JP Morgan Chase
New York
– -$183 -46 Closed
Barclays
24
Barclays
United Kingdom
– -$56 -14 Closed
CFD
25
Creative Financial Designs
Indiana
– -$24 -6 Closed
1
2

CLSD Hedge Fund Activity: Q4 2025 in Review

1 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Clearside Biomedical (CLSD) for Q4 2025, worth a combined $19.1K — down 99% from $2.18M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of CLSD and 1 opened new positions — a net loss of 25 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was DRW Securities, opening a new position worth an estimated $95.6K. The largest seller was Vanguard Group, exiting entirely with an estimated $881K sold.

  • 1 institutional investor held Clearside Biomedical (CLSD) as of Q4 2025, down from 26 in Q3 2025.
  • Funds reported $19.1K of Clearside Biomedical stock for Q4 2025, down 99% quarter-over-quarter.
  • 1 fund opened new Clearside Biomedical positions in Q4 2025 and 26 closed out, a net change of -25 holders.
  • The largest Clearside Biomedical buyer in Q4 2025 was DRW Securities, an estimated $95.6K added.
  • The largest Clearside Biomedical seller in Q4 2025 was Vanguard Group, an estimated $881K sold.

Based on aggregated 13F filings for Q4 2025.